Skip to content

An observational study of the effects of multidimensional factors such as mood, exercise, and sleep on the outcome of hematopoietic stem cell transplantation patients

An observational study of the effects of multidimensional factors such as mood, exercise, and sleep on the outcome of hematopoietic stem cell transplantation patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106265
Enrollment
Unknown
Registered
2025-07-21
Start date
2025-07-31
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with hematologic malignancies who have undergone hematopoietic stem cell transplantation

Interventions

Case series:NA

Sponsors

The Second Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 18 years old<= age <= 70 years old, gender is not limited; 2. Patients diagnosed with the need for hematopoietic stem cell transplantation (HSCT), including allogeneic and autologous hematopoietic stem cell transplantation; 3. Have completed pre-transplant evaluation prior to transplantation and are candidates for HSCT; 4. Ability to complete the filling of the scale questionnaire; 5. Able to accept follow-up and willing to cooperate with the investigator to complete the study requirements; 6. Signed informed consent;

Exclusion criteria

Exclusion criteria: 1. Comorbid severe psychiatric disorder or cognitive dysfunction that precludes accurate assessment of mood, motor, and sleep status; 2. Patients who have received prior hematopoietic stem cell transplantation or other significant therapeutic interventions that may affect the study data; 3. Presence of serious complications (e.g., organ failure, active infection) prior to transplantation that may affect the evaluation of transplant outcomes; 4. Pregnant or lactating females; 5. Those who are expected to be at higher risk of loss to follow-up due to relocation or other reasons during the follow-up period; 6. Special circumstances that other investigators consider inappropriate to participate in the study;

Design outcomes

Primary

MeasureTime frame
Acute severe graft-versus-host disease;

Secondary

MeasureTime frame
Time to neutrophil and platelet engraftment;Overall Survival Rate;Quality of life;Recurrence rate;Incidence of non-severe acute GVHD and chronic GVHD;

Countries

China

Contacts

Public ContactZhang Xi

The Second Affiliated Hospital of the Army Medical University

zhangxxi@sina.com+86 23 6876 3198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026